First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study
Shigeo Shimose(Kurume University), Takuji Torimura(Omuta hospital), Masahito Nakano(Kurume University), Hajime Aino, Masahiko Kajiwara, Hironori Koga(Kurume University), Naoki Kamachi(Kurume University), Norito Matsukuma(Yokkaichi Social Insurance Hospital), Kazunori Noguchi(Omuta hospital), Atsushi Hiraoka(Ehime Prefectural Central Hospital), Hideya Suga(Yanagawa Rehabilitation Hospital), Takaaki Tanaka(Okayama University), Masatoshi Tanaka(Fukushima Medical University), Hideki Iwamoto, Takashi Niizeki(Kurume University), Hiroshi Kawano(St. Mary’s Hospital), Takumi Kawaguchi(Kurume University), Taizo Yamaguchi, Yoshinori Yokokura(ShinKokura Hospital), Satoshi Itano(Kurume University Hospital), Kei Ogata(Kurume University), Yu Noda(Kurume University), Shusuke Okamura(Kurume University), Tomotake Shirono(Kurume University)
Cited by 16
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504